Pierre joined Amadeus Capital Partners in 2012 and leads early stage Health & Bio investments at Amadeus. He is on the boards of Inotec, Ori Biotech, Doctify, Congenica, PhoreMost and oversees our investment in Organox.
Pierre brings operational experience to these investments, having managed the growth of several life science businesses in Asia and Europe. During a decade at biotech company Avesthagen, he guided the group’s strategy and European activities, contributing to acquisitions, joint ventures and exits.
Pierre is French and holds an MSc in Environmental Economics (Hons.-SciencesEco) from Université de Provence, France and a BSc in Finance (Math Spe.-SciencesEco) from Université Louis Pasteur, France. He has attended executive programs at Harvard, MIT and Stanford.
Pierre speaks French and English.
Meet Pierre at:
18th November 2020
European Wound Management Association Annual Conference
Pierre Socha will be attending the annual European Wound Management Association Conference (EWMA) in London. The EWMA Conference is organised in cooperation with Tissue Viability Society (TVS) and offers high-level scientific presentations, networking activities and an excellent opportunity to exchange knowledge and experience with international colleagues.
More from Pierre
Blog: 9th January 2020
Blog: 18th December 2019